- Bekaii-Saab, T., Okusaka, T., Goldstein, D., Oh, D. -., Ueno, M., Ioka, T., Tabernero, J., . . . Van Cutsem, E. (2023). Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: An adaptive multicentre, randomised, open-label, phase 3, superiority trial. EClinicalMedicine, 58. https://doi.org/10.1016/j.eclinm.2023.101897
Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: An adaptive multicentre, randomised, open-label, phase 3, superiority trial
on 11 d'abril de 2023
with No hi ha comentaris
Deixa un comentari